Dr. Daniel D. Dulas, M.D.
Interventional Cardiology (Interventional Cardiology Physician)
- Medicare participating
At a glance
- Medical school
- University of Minnesota Medical School (1986)
- Years since graduation
- 40
- In the NPI registry since
- 2006
- Medicare patients seen, 2024
- 384
The NPI date is when this clinician registered for a National Provider Identifier, the billing number used on health claims. It is not a license, graduation or board-certification date. NPIs were first issued in May 2005 and became required on claims in 2007–2008, so an early date usually means the clinician was already in practice before then. What an NPI is
Education and training
- 1986Medical school: University of Minnesota Medical School
- 2006Registered with an NPI (national billing number; not a license date) — NPIs began in 2005, so practice likely started earlier
Undergraduate school, residency, fellowship, licensing exams and board certification aren’t in public federal data. Board certification can be confirmed with the certifying board (ABMS member boards for MDs, AOA boards for DOs).
Specialties and state licenses
-
Interventional Cardiology Physician primary
MN license 33752 -
Internal Medicine Physician
MN license 33752
As reported to the NPI registry. To confirm a license is current, check the state medical board.
Where they work
Hospitals
- Mercy Hospital Coon Rapids, MN
- Buffalo Hospital Buffalo, MN
Medical groups
- Allina Health System (3,842 clinicians)
Hospitals this clinician lists with Medicare, and groups they bill Medicare through (Care Compare). Affiliation doesn’t mean they see patients at every location.
Medicare patients and services
- Medicare patients, 2024
- 384
- Services billed
- 800
- Patients’ average age
- 75
| Service | Times | Patients |
|---|---|---|
| Anticoagulant management of patient taking warfarin | 85 | 70 |
| Use of a drug to induce depression of consciousness by physician performing a procedure (5 years or older), initial 15 minutes | 69 | 60 |
| Blood test, clotting time | 64 | 56 |
| Insertion of stents with balloon dilation of coronary artery or branch, single artery or branch | 41 | 27 |
| Ultrasound of both sides of head and neck blood flow | 39 | 39 |
| Established patient office or other outpatient visit, 30-39 minutes | 35 | 33 |
| Insertion of tube in left lower heart chamber and coronary artery for diagnosis with review by radiologist | 34 | 34 |
| Subsequent hospital care with moderate levelof medical decision making, if using time, at least 35 minutes | 31 | 23 |
| Ultrasound study of arm or leg veins with compression and maneuvers | 27 | 27 |
| Ultrasound evaluation of heart blood vessel during diagnosis or treatment, initial vessel | 26 | 23 |
Medicare fee-for-service only. CMS leaves out services billed for fewer than 11 patients. These figures describe a practice’s Medicare work; they aren’t a measure of quality.
Medicare prescriptions
| Drug | Prescriptions |
|---|---|
| Clopidogrel (clopidogrel bisulfate) Other prescribers in Minneapolis, MN | 166 |
| Atorvastatin Calcium Other prescribers in Minneapolis, MN | 146 |
| Metoprolol Succinate Other prescribers in Minneapolis, MN | 142 |
| Lisinopril Other prescribers in Minneapolis, MN | 87 |
| Rosuvastatin Calcium Other prescribers in Minneapolis, MN | 87 |
| Isosorbide Mononitrate Er (isosorbide mononitrate) Other prescribers in Minneapolis, MN | 76 |
| Metoprolol Tartrate Other prescribers in Minneapolis, MN | 69 |
| Carvedilol Other prescribers in Minneapolis, MN | 45 |
| Furosemide Other prescribers in Minneapolis, MN | 39 |
| Amlodipine Besylate Other prescribers in Minneapolis, MN | 35 |
Prescriptions filled under Medicare Part D, including refills. CMS leaves out drugs prescribed fewer than 11 times.
Payments from drug and device companies
In 2025, 7 companies reported 10 payments worth $202 in total to this clinician.
| Stryker Corporation | $53.65 |
|---|---|
| Abbott Laboratories | $52.55 |
| Bard Peripheral Vascular, Inc. | $25.14 |
| Biotronik Inc. | $21.15 |
| Recor Medical Inc | $17.70 |
| Terumo Medical Corporation | $16.30 |
| Philips North America LLC | $15.50 |
| Food and Beverage | $202 |
|---|
From CMS Open Payments. A payment is not evidence of wrongdoing; many are for consulting, teaching or meals. Clinicians can review and dispute their records with CMS.
Industry-funded research
Named as a principal investigator on 2 industry-funded studies in 2025, from 2 companies. The companies reported $12,759 in research payments for these studies, mostly to the institutions running them.
- Evaluation of Treatment Strategies for Severe CaLcIfic Coronary Arteries: Orbital Atherectomy vs. Conventional Angioplasty Technique Prior to Implantation of Drug-Eluting StEnts: The ECLIPSE Trial
Abbott Laboratories · Active, not recruiting · NCT03108456 - Drug-Eluting Registry: Real-World Treatment of Lesions in the Peripheral Vasculature
Boston Scientific Corporation · Recruiting · NCT04674969
From CMS Open Payments research payments, where companies name up to five principal investigators per payment. Research payments usually go to hospitals, universities and research sites, not to the investigator personally. A payment is not evidence of wrongdoing.